eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
4.110
-0.115 (-2.72%)
Oct 29, 2026, 4:00 PM EDT - Market closed
eXoZymes Employees
eXoZymes had 32 employees as of December 31, 2025. The number of employees increased by 1 or 3.23% compared to the previous year. That makes eXoZymes the 36,836th largest employer in the world and 5,099th in the United States.
Employees
32
Change (1Y)
1
Growth (1Y)
3.23%
Revenue / Employee
n/a
Profits / Employee
-$318,465
Market Cap
38.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 32 | 1 | 3.23% |
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| IRulya Therapeutics | 38 |
| Veru Inc. | 20 |
| Edesa Biotech | 17 |
| Instil Bio | 17 |
| CervoMed | 15 |
| Dogwood Therapeutics | 8 |
| NanoViricides | 7 |
EXOZ News
- 8 days ago - eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research - Accesswire
- 24 days ago - eXoZymes Slides: Investor presentation - Filings
- 27 days ago - Water Tower Research Publishes Initiation of Coverage Report on eXoZymes, Inc., "Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity" - TheNewswire
- 4 weeks ago - eXoZymes Proxy statement: Proxy filing - Filings
- 4 weeks ago - eXoZymes Proxy statement: Proxy filing - Filings
- 7 weeks ago - eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT - Accesswire
- 2 months ago - eXoZymes Inc trading resumes - TheFly
- 2 months ago - eXoZymes Inc trading halted, volatility trading pause - TheFly